Welcome to the ALIFE2 Study homepage

In total there will be 399 inclusions, approximately 100 will be performed by the NL-team (including all international non-UK sites) and 300 will be done by the UK-team.


Total randomizations: 150/399


Total registrations NL-team : 80/100

Total randomizations NL-team: 78/100

Total registrations UK-team: 122/300

Total randomizations UK-team: 72/300  

Last update: 16-03-2018

 

Anticoagulants for living fetuses in women with recurrent miscarriage and inherited thrombophilia

NTR 3361

METC 2012_173

ABR NL40256.018.12


Are you an (international) physician willing to participate in the ALIFE2 study? please contact Luuk Scheres at l.j.scheres@amc.uva.nl.

 

News


May 2017

CHU Sainte-Justine in Montreal, Canada has opened for recruitment!

December 2016


First ALIFE2 randomization in University Medical Center Ljubljana!

October 2016


Great news! First ALIFE2 randomization in the USA! The University of Illinois at Chicago has included the first participant!

May 2016

The University Medical Center Ljubljana in Slovenia has opened for recruitment!

January 2016

The University of Illinois at Chicago has opened for recruitment!

October 2015

Warwick Medical School, the first UK-ALIFE2 team (NHS grant) site has opened for inclusion!!

May 2015

The ALIFE2 protocol has been published in TRIALS! (link here)